Management ChangeMay 7, 2026, 04:32 PM
STERIS Appoints Pierre Boulud to Board of Directors
AI Summary
STERIS plc announced the appointment of Pierre Boulud to its Board of Directors, effective May 5, 2026. Mohsen Sohi, Chairman of STERIS, highlighted Boulud's leadership experience, global perspective, strategic acumen, and operational expertise as valuable additions. Boulud currently serves as CEO of bioMérieux and previously held significant roles at Ipsen and The Boston Consulting Group.
Key Highlights
- Pierre Boulud appointed to STERIS plc Board of Directors, effective May 5, 2026.
- Boulud is currently the CEO of bioMérieux, a world leader in in vitro diagnostics, a role he has held since 2023.
- He joined bioMérieux in 2016 as Corporate Vice President, Head of Asia Pacific Region, and was promoted to Chief Operating Officer in 2020.
- Prior to bioMérieux, Boulud spent fourteen years at Ipsen, a global specialty-driven biotechnological group.
- Mohsen Sohi, Chairman of STERIS, stated Boulud's leadership, global perspective, strategic acumen, and operational expertise make him an excellent addition.
Price Impact
More from STE